Lipocalin 2 /NGAL ELISA

• SK00233-02
• Serum or Plasma
• 50-fold dilution required
• Biomarker for Kidney Injury or Renal Failure

1: Wu Y, Su T, Yang L, Zhu SN, Li XM. Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis. Am J Med Sci. 2010 Jun;339(6):537-42.

2: Shaker O, El-Shehaby A, El-Khatib M. Early Diagnostic Markers for Contrast Nephropathy in Patients Undergoing Coronary Angiography. Angiology. 2010 Jun 7. [Epub ahead of print].

3: Eagan TM, Damås JK, Ueland T, Voll-Aanerud M, Mollnes TE, Hardie JA, Bakke PS, Aukrust P. Neutrophil Gelatinase Associated Lipocalin - a biomarker in Chronic Obstructive Pulmonary Disease. Chest. 2010 May 21. [Epub ahead of print]

4: Allison SJ. Lupus nephritis: Urinary NGAL predicts renal flares in lupus nephritis. Nat Rev Nephrol. 2010 May;6(5):250.

5: Yang HN, Boo CS, Kim MG, Jo SK, Cho WY, Kim HK. Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in  acute kidney injury. Am J Nephrol. 2010;31(6):501-9. Epub 2010 May 4.